Pathstone Family Office, LLC Medi Wound Ltd. Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 23, 2023
BUY
$1.33 - $2.35 $13,300 - $23,500
10,000 New
10,000 $18,000
Q1 2022

May 16, 2022
BUY
$1.86 - $3.24 $18,600 - $32,400
10,000 New
10,000 $20,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $707M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email